GPT and fatty liver disease: Among mice on a 0.5% cholesterol, there were no differences between those that received MCC950 and those that did not in all parameters measured, including levels of plasma AST, ALT and ALP, hepatic lipid composition and hepatic steatosis, inflammation, and fibrosis.